Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hoshi Iryo-Sanki Co's Other Operating Expense for the
three
months ended in Mar. 2026 was 円1,426 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円5,758 Mil.
Hoshi Iryo-Sanki Co's quarterly Other Operating Expense
increased
from Sep. 2025 (円1,377 Mil) to Dec. 2025 (円1,446 Mil) but then
declined
from Dec. 2025 (円1,446 Mil) to Mar. 2026 (円1,426 Mil).
Hoshi Iryo-Sanki Co's annual Other Operating Expense
increased
from Mar. 2024 (円4,762 Mil) to Mar. 2025 (円5,081 Mil) and
increased
from Mar. 2025 (円5,081 Mil) to Mar. 2026 (円5,250 Mil).
Hoshi Iryo-Sanki Co Other Operating Expense Related Terms
Hoshi Iryo-Sanki Co Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Hoshi Iryo-Sanki Co's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円5,758 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of 円5,758 Mil mean?
Hoshi Iryo-Sanki Co (TSE:7634) has a Other Operating Expense of 円5,758 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Hoshi Iryo-Sanki Co and its competitors.
Is Hoshi Iryo-Sanki Co's Other Operating Expense too high?
Hoshi Iryo-Sanki Co's current Other Operating Expense is 円5,758 Mil. Overall, Hoshi Iryo-Sanki Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hoshi Iryo-Sanki Co's Other Operating Expense compare to MCK and COR?
Hoshi Iryo-Sanki Co's Other Operating Expense of 円5,758 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Distribution company?
A good Other Operating Expense depends on the Medical Distribution industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Hoshi Iryo-Sanki Co and its competitors. Hoshi Iryo-Sanki Co's current Other Operating Expense is 円5,758 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoshi Iryo-Sanki Co stock overvalued right now?
Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co (TSE:7634) is currently considered Fairly Valued. The stock's GF Value™ is 円4,730.78, compared to a current price of 円5,200.00 — trading 9.9% above its estimated fair value. The current Other Operating Expense is 円5,758 Mil. Hoshi Iryo-Sanki Co's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Hoshi Iryo-Sanki Co (TSE:7634), the current Other Operating Expense is 円5,758 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hoshi Iryo-Sanki Co (TSE:7634) Overvalued in 2026?
Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co stock appears to be overvalued.
The current stock price of 円5,200.00 is trading 9.9% above its estimated GF Value™ of 円4,730.78.
GuruFocus considers Hoshi Iryo-Sanki Co to be Fairly Valued.
Key valuation signals for TSE:7634:
Other Operating Expense: 円5,758 Mil
GF Value™: 円4,730.78 vs. price of 円5,200.00 (9.9% above fair value)
No single metric tells the full story. See the TSE:7634 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hoshi Iryo-Sanki Co Ltd is engaged in the manufacturing and sale of pharmaceutical products. The company offers medical oxygen, nitrous oxide, and others. It is also engaged in the planning, manufacture, sale, maintenance, inspection, and repair of medical instrument equipment for medical gas supply facilities. The company's project service includes the production and supply of medical gas, home care, medical gas maintenance, and others.
81GF Score
Get the complete analysis for TSE:7634
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7634 has been successfully added to your 
